2024

Cyclomics, a pioneering leader in molecular diagnostic solutions, is proud to announce that co-founder Wigard Kloosterman has taken on the role of Chief Executive Officer (CEO). This strategic leadership transition follows Wigard’s successful tenure at Frame Therapeutics – currently named CuraVac Netherlands, after the acquisition by CureVac – where his innovative contributions and visionary leadership significantly propelled the company. At… Read More »Cyclomics Announces Appointment of Wigard Kloosterman as Full-Time CEO to accelerate its independent future

The combined Companies aim to Disrupt Cancer Diagnosis and treatment through early disease and recurrence detection, prediction of response to treatment, and personalized therapy. LOS ANGELES, Feb. 13, 2024 (GLOBE NEWSWIRE) — GEDi Cube Intl Ltd., a London and Netherlands-based advanced AI company and a wholly owned subsidiary of Renovaro Inc. (NASDAQ: RENB), announces it has executed a binding Letter… Read More »Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace